Literature DB >> 20414726

Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity.

Geoffrey C Wall1, Jane E Dewitt, Sally Haack, Anisa Fornoff, Darla K Eastman, Carrie F Koenigsfeld.   

Abstract

OBJECTIVE: Pharmacists are commonly confronted with patients with a history of sulfonamide allergy. Basic immunologic and clinical data suggest a low likelihood of a patient with a history of sulfonamide hypersensitivity developing an allergic reaction to a non-antimicrobial sulfonamide drug. We conducted a survey to describe the knowledge and attitudes of licensed pharmacists concerning sulfonamide allergy cross-reactivity.
METHODS: A survey instrument was developed and sent to all licensed pharmacists in the state of Iowa. The survey recorded demographic information and included six patient scenarios designed to elicit responses concerning sulfonamide allergy cross-reactivity with a number of non-antimicrobial sulfonamides.
RESULTS: A total of 421 surveys were returned for a 39% response rate. There was a wide discrepancy in approaches to patients with a history of sulfonamide allergy prescribed a sulfonamide containing non-antibiotic. Differences depended on previous history of tolerating the medication in question, the degree of cautionary statements in product literature, and the familiarity the pharmacist had with the product.
CONCLUSION: Our survey suggests a significant diversity in knowledge and attitudes of pharmacists concerning cross-reactivity of sulfonamide antimicrobials and other drugs with a sulfonamide moiety. Depth of training in this area may be an associative factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414726     DOI: 10.1007/s11096-010-9389-6

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  5 in total

Review 1.  Drug hypersensitivities: definition, epidemiology and risk factors.

Authors:  P Demoly; E Rebelo Gomes
Journal:  Eur Ann Allergy Clin Immunol       Date:  2005-06

2.  Immunologic tolerability profile of celecoxib.

Authors:  R Patterson; A E Bello; J Lefkowith
Journal:  Clin Ther       Date:  1999-12       Impact factor: 3.393

3.  Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.

Authors:  John Farrell; Dean J Naisbitt; Nicola S Drummond; Jan P H Depta; F Javier Vilar; Munir Pirmohamed; B Kevin Park
Journal:  J Pharmacol Exp Ther       Date:  2003-04-03       Impact factor: 4.030

4.  Role of pharmacist counseling in preventing adverse drug events after hospitalization.

Authors:  Jeffrey L Schnipper; Jennifer L Kirwin; Michael C Cotugno; Stephanie A Wahlstrom; Brandon A Brown; Emily Tarvin; Allen Kachalia; Mark Horng; Christopher L Roy; Sylvia C McKean; David W Bates
Journal:  Arch Intern Med       Date:  2006-03-13

5.  Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.

Authors:  Brian L Strom; Rita Schinnar; Andrea J Apter; David J Margolis; Ebbing Lautenbach; Sean Hennessy; Warren B Bilker; Dan Pettitt
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

  5 in total
  3 in total

Review 1.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

2.  Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients.

Authors:  K F Urbancic; F Ierino; E Phillips; P F Mount; A Mahony; J A Trubiano
Journal:  Am J Transplant       Date:  2017-10-03       Impact factor: 8.086

Review 3.  Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.

Authors:  Katherine C Konvinse; Elizabeth J Phillips; Katie D White; Jason A Trubiano
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.